DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
170 hedge funds and large institutions have $1.59B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 64 increasing their positions, 53 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more funds holding
Funds holding: 144 → 170 (+26)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
170
Holding in Top 10
5
Calls
$4.15M
Puts
$2.03M
Top Buyers
| 1 | +$30.1M | |
| 2 | +$22.2M | |
| 3 | +$20.3M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$18.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$12M |
Top Sellers
| 1 | -$26.6M | |
| 2 | -$20.5M | |
| 3 | -$19.7M | |
| 4 |
Goldman Sachs
New York
|
-$17.2M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$15.9M |